Hadi HA, Tarmizi AI, Khalid KA, Gajdacs M, Aslam A, Jamshed S (2021) The epidemiology and global burden of atopic dermatitis: A narrative review. Life (Basel) 11(9). https://doi.org/10.3390/life11090936

Xue Y, Bao W, Zhou J, Zhao QL, Hong SZ, Ren J et al (2022) Global Burden, incidence and Disability-Adjusted Life-Years for dermatitis: A systematic analysis combined with socioeconomic development Status 12-2022:1990–2019. https://doi.org/10.3389/fcimb.2022.861053

Laughter MR, Maymone MBC, Mashayekhi S, Arents BWM, Karimkhani C, Langan SM et al (2021) The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017. Br J Dermatol 184(2):304–9. https://doi.org/10.1111/bjd.19580

Article  CAS  PubMed  Google Scholar 

Brown SJ, McLean WH (2012) One remarkable molecule: filaggrin. J Invest Dermatol 132(3 Pt 2):751–762. https://doi.org/10.1038/jid.2011.393

Article  CAS  PubMed  Google Scholar 

Czarnowicki T, He H, Krueger JG, Guttman-Yassky E (2019) Atopic dermatitis endotypes and implications for targeted therapeutics. J Allergy Clin Immunol 143(1):1–11. https://doi.org/10.1016/j.jaci.2018.10.032

Article  PubMed  Google Scholar 

Sanyal RD, Pavel AB, Glickman J, Chan TC, Zheng X, Zhang N et al (2019) Atopic dermatitis in African American patients is T(H)2/T(H)22-skewed with T(H)1/T(H)17 attenuation. Ann Allergy Asthma Immunol 122(1):99-110 e6. https://doi.org/10.1016/j.anai.2018.08.024

Article  CAS  PubMed  Google Scholar 

Nguyen GH, Andersen LK, Davis MDP (2019) Climate change and atopic dermatitis: is there a link? Int J Dermatol 58(3):279–282. https://doi.org/10.1111/ijd.14016

Article  PubMed  Google Scholar 

Liu P, Zhao Y, Mu ZL, Lu QJ, Zhang L, Yao X et al (2016) Clinical features of adult/adolescent atopic dermatitis and Chinese criteria for atopic dermatitis. Chin Med J (Engl) 129(7):757–62. https://doi.org/10.4103/0366-6999.178960

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yew YW, Thyssen JP, Silverberg JI (2019) A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics. J Am Acad Dermatol 80(2):390–401. https://doi.org/10.1016/j.jaad.2018.09.035

Article  PubMed  Google Scholar 

Schuler C, Billi AC, Maverakis E, Tsoi LC, Gudjonsson JE (2023) Novel insights into atopic dermatitis. J Allergy Clin Immunol 151(5):1145–54. https://doi.org/10.1016/j.jaci.2022.10.023

Article  CAS  PubMed  Google Scholar 

Zhang XE, Zheng P, Ye SZ, Ma X, Liu E, Pang YB et al (2024) Microbiome: role in inflammatory skin diseases. J Inflamm Res 17:1057–1082. https://doi.org/10.2147/JIR.S441100

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agulló-Pérez AD, Hervella-Garcés M, Oscoz-Jaime S, Oscoz-Jaime S, Azcona-Rodríguez M, Azcona-Rodríguez M, Larrea-García M, Larrea-García M, Yanguas-Bayona J-I, Yanguas-Bayona JI (2017) Perianal dermatitis. Dermatitis 28(4):270–5. https://doi.org/10.1097/DER.0000000000000274

Article  PubMed  Google Scholar 

Krishnan A, Kar S (2013) Scrotal dermatitis - can we consider it as a separate entity? Oman Med J 28(5):302–305. https://doi.org/10.5001/omj.2013.91

Article  PubMed  PubMed Central  Google Scholar 

Girolomoni G, de Bruin-Weller M, Aoki V, Kabashima K, Deleuran M, Puig L et al (2021) Nomenclature and clinical phenotypes of atopic dermatitis. Ther Adv Chronic Dis 12:20406223211002979. https://doi.org/10.1177/20406223211002979

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A et al (2018) Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol 32(5):657–82. https://doi.org/10.1111/jdv.14891

Article  CAS  PubMed  Google Scholar 

Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S et al (2022) European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy. J Eur Acad Dermatol Venereol 36(9):1409–31. https://doi.org/10.1111/jdv.18345

Article  CAS  PubMed  Google Scholar 

Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN et al (2014) Guidelines of care for the management of atopic dermatitis: Sect. 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol 71(2):327–349. https://doi.org/10.1016/j.jaad.2014.03.030

Article  PubMed  PubMed Central  Google Scholar 

Beck LA, Bissonnette R, Deleuran M, Nakahara T, Galus R, Coleman A et al (2024) Dupilumab in adults with moderate to severe atopic dermatitis: a 5-year open-label extension study. JAMA Dermatol 160(8):805–12. https://doi.org/10.1001/jamadermatol.2024.1536

Article  PubMed  PubMed Central  Google Scholar 

Silverberg JI, Guttman-Yassky E, Thaci D, Irvine AD, Stein Gold L, Blauvelt A et al (2023) Two phase 3 trials of lebrikizumab for moderate-to-severe atopic dermatitis. N Engl J Med 388(12):1080–91. https://doi.org/10.1056/NEJMoa2206714

Article  CAS  PubMed  Google Scholar 

Guttman-Yassky E, Brunner PM, Neumann AU, Khattri S, Pavel AB, Malik K et al (2018) Efficacy and safety of Fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial. J Am Acad Dermatol 78(5):872–881. https://doi.org/10.1016/j.jaad.2018.01.016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kabashima K, Matsumura T, Komazaki H, Kawashima M, Nemolizumab JPSG (2022) Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate-to-severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: results from two phase III, long-term studies. Br J Dermatol 186(4):642–651. https://doi.org/10.1111/bjd.20873

Article  CAS  PubMed  Google Scholar 

Weidinger S, Bieber T, Cork MJ, Reich A, Wilson R, Quaratino S et al (2023) Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial. Br J Dermatol 189(5):531–9. https://doi.org/10.1093/bjd/ljad240

Article  CAS  PubMed  Google Scholar 

Werfel T, Heratizadeh A, Aberer W, Augustin M, Biedermann T, Bauer A et al (2024) S3 guideline atopic dermatitis: part 1 - General aspects, topical and non-drug therapies, special patient groups. J Dtsch Dermatol Ges 22(1):137–153. https://doi.org/10.1111/ddg.15230

Article  PubMed  Google Scholar 

Proudfoot LE, Powell AM, Ayis S, Barbarot S, Baselga Torres E, Deleuran M et al (2013) The European TREatment of severe atopic eczema in children taskforce (TREAT) survey. Br J Dermatol 169(4):901–9. https://doi.org/10.1111/bjd.12505

Article  CAS  PubMed  Google Scholar 

Patruno C, Napolitano M, Argenziano G, Peris K, Ortoncelli M, Girolomoni G et al (2021) Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study. J Eur Acad Dermatol Venereol 35(4):958–64. https://doi.org/10.1111/jdv.17094

Article  CAS  PubMed  Google Scholar 

Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, Group IPTS (2009) Global variations in prevalence of eczema symptoms in children from ISAAC phase three. J Allergy Clin Immunol 124(6):1251–1258. https://doi.org/10.1016/j.jaci.2009.10.009

Article  PubMed  Google Scholar 

Shaw TE, Currie GP, Koudelka CW, Simpson EL (2011) Eczema prevalence in the United States: data from the 2003 National survey of children’s health. J Invest Dermatol 131(1):67–73. https://doi.org/10.1038/jid.2010.251

Article  CAS  PubMed  Google Scholar 

Janumpally SR, Feldman SR, Gupta AK, Fleischer AB Jr. (2002) In the United States, blacks and Asian/Pacific Islanders are more likely than whites to seek medical care for atopic dermatitis. Arch Dermatol 138(5):634–7. https://doi.org/10.1001/archderm.138.5.634

Williams HC, Pembroke AC, Forsdyke H, Boodoo G, Hay RJ, Burney PG (1995) London-born black Caribbean children are at increased risk of atopic dermatitis. J Am Acad Dermatol 32(2 Pt 1):212–7. https://doi.org/10.1016/0190-9622(95)90128-0

Article  CAS  PubMed  Google Scholar 

Kim Y, Blomberg M, Rifas-Shiman SL, Camargo CA Jr., Gold DR, Thyssen JP et al (2019) Racial/Ethnic Differences in Incidence and Persistence of Childhood Atopic Dermatitis. J Invest Dermatol 139(4):827–34.